The Importance of Targeting Lipid Metabolism in Parasites for Drug Discovery

Medicine and Dentistry

• Diseases 100%
• Lipid Metabolism 100%
• Visceral Leishmaniasis 66%
• Cutaneous Leishmaniasis 33%
• African Trypanosomiasis 33%
• Chagas Disease 33%
• Infection 33%
• Trypanosoma Brucei 33%
• Life Cycle 33%
• Drug Resistance 33%
• Protozoa 33%
• Disease Burden 33%
• Leishmania 33%
• Precursor 33%
• Parasite Survival 33%
• Trypanosoma Cruzi 33%
• Medicine 33%
• Morphology 33%
• Apicomplexa 33%
• Signaling Molecule 33%
• Tumor Cell 33%

Immunology and Microbiology

• Lipid Metabolism 100%
• Protozoa 66%
• Visceral Leishmaniasis 66%
• Cutaneous Leishmaniasis 33%
• Apicomplexa 33%
• Morphology 33%
• Toxoplasma 33%
• Tumor Cell 33%
• Chagas Disease 33%
• Drug Resistance 33%
• Life Cycle 33%
• Precursor 33%
• Parasite Survival 33%
• Trypanosoma Brucei 33%
• Cryptosporidium 33%
• Leishmania 33%
• Disease Burden 33%
• Trypanosoma Cruzi 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Drug Discovery 100%
• Protozoon 50%
• Visceral Leishmaniasis 50%
• Leishmania 25%
• Cryptosporidium 25%
• Apicomplexa 25%
• Trypanosoma Brucei 25%
• Neoplasm 25%
• Drug Resistance 25%
• Skin Leishmaniasis 25%
• Toxoplasma 25%
• Chagas Disease 25%
• Trypanosoma Cruzi 25%
• Infection 25%
• African Trypanosomiasis 25%